The rapid increase in bacterial resistance to antimicrobial therapies is a serious global public health concern, threatening the efficacy of current treatment options and undermining infection control efforts across clinical and environmental settings (
20,
30). The marine ecosystem is a storehouse of diverse microorganisms, including pathogenic and non-pathogenic bacteria capable of acquiring and disseminating antibiotic resistance genes (
11,
12,
18-
21). A holistic approach and comprehensive understanding of the antibiotic sensitivity profile both in clinical and environmental settings are key to addressing this alarming public health challenge. However, AMR in marine ecosystems has not been extensively studied compared to that found in clinical settings (
18-
21,
31). The findings from this study revealed the two isolates as
Pseudomonas aeruginosa (S1) and
Escherichia coli (S2). The presence of
P. aeruginosa and
E. coli from Lagos marine water strongly indicates fecal and industrial contamination, and this finding aligns with previous studies conducted in Lagos Lagoon and other Nigerian coastal ecosystems (
4,
5,
32,
33). Both isolates demonstrated distinct physiological and biochemical traits that reflect their adaptive diversity and metabolic specialization in aquatic environments. The biochemical characterization differentiated
P. aeruginosa from
E. coli based on their substrate utilization patterns and enzyme production profiles. S1 was catalase-positive, citrate-positive, indole-negative, and unable to ferment glucose, lactose, or mannitol. These features align with the well-established descriptions of
P. aeruginosa as non-fermentative, oxidase-positive organisms with broad metabolic flexibility and environmental resilience (
34). In contrast,
E. coli (S2) showed classical
Enterobacteriales characteristics, including indole production, MR positive, and the ability to ferment multiple sugars with acid and gas production. These results supported the writings of a number of authors, including Bopp et al. (
35), Madigan et al. (
36), and Leimbach et al. (
37). The metabolic differences between the isolates indicate ecological adaptation and niche specialization.
Pseudomonas aeruginosa, being a non-fermentative bacterium, primarily derives energy through oxidative metabolism, which enables its efficient survival in oxygen-rich marine environments. In contrast,
E. coli depends largely on fermentative pathways, which suggest possible fecal contamination of the marine ecosystem (
33). Therefore, the recovery of
E. coli from Lagos marine water indicates human-induced pollution, and this finding is consistent with previous studies that reported high levels of fecal coliforms and enteric bacteria in different sites on coastal water in Lagos (
6,
7,
38). Both
P. aeruginosa and
E. coli are well known opportunistic pathogens with substantial clinical importance.
Pseudomonas aeruginosa, are associated with burn wound infections, respiratory diseases, otitis externa, and bacteremia (
39-
41).
Escherichia coli encompasses several pathogenic pathotypes enteropathogenic, enterotoxigenic, enteroinvasive, and enterohemorrhagic which are responsible for gastrointestinal infections ranging from mild diarrhea to hemorrhagic colitis (
35,
42-
44).
The antibiotic susceptibility testing revealed MDR in both isolates, particularly to nitrofurantoin, ampicillin, and tetracycline.
Pseudomonas aeruginosa exhibited additional resistance to NA, GEN, and STR, whereas
E. coli was sensitive to NA and GEN but showed intermediate resistance to cotrimazole and STR. These variations underscore species-specific differences in antibiotic resistance mechanisms, possibly due to genetic factors and environmental exposure (
45,
46). These findings are consistent with previous reports from Lagos and other aquatic environments in Nigeria that documented MDR
P. aeruginosa and
E. coli strains (
33,
47-
49). Moreover, the observed resistance to tetracycline and β-lactams (AMP) corroborates earlier findings from aquatic systems in Lagos and other parts of Nigeria, where
P. aeruginosa and
E. coli isolates harbored transferable tetracycline resistance genes (tetA, tetB, tetM) and β-lactamase genes (
5,
33,
49,
50). These genes are often found on plasmid, and can be transferred among marine and enteric bacteria (
48). The co-resistance to aminoglycosides (GEN, STR) observed in
P. aeruginosa further supports the possibility of mobile genetic element-mediated dissemination of MDR factors, a phenomenon well-documented in studies of aquatic ecosystems by Meradji et al. (
50) and Pazra et al. (
51). Furthermore, both isolates remained susceptible to COL, although this finding may suggest it continued efficacy against these marine isolates, but it has to be interpreted with caution due the increasing detection of plasmid-mediated COL resistance in African isolates (
52-
54) and lack of further confirmation test in this study. Therefore, this observation warrants further research to validate its exact efficacy and to evaluate its broader clinical implications. Globally, MDR in marine-derived
P. aeruginosa and
E. coli has been increasingly reported. Studies from Tunisia (
50), India (
55), Poland (
46), and Brazil (
56) describe similar resistance patterns particularly to tetracycline, β-lactams, and sulfonamides which suggesting that the isolates from marine water in Lagos are part of a global environmental trend of antibiotic resistance in coastal waters. The persistence of tetracycline resistance in marine environments may be attributed to the extensive use of this antibiotic in aquaculture and livestock, with subsequent runoff into the marine system (
46,
51-
56). The detection of MDR bacteria in Lagos marine waters has substantial ecological and public-health implications. Coastal waters near urban centers such as Lagos often receive untreated or poorly treated effluents from hospitals, industries, and households, contributing to a complex mixture of antibiotics, resistant bacteria, and resistance genes (
38,
56). These conditions create a conducive environment for the selection and transfer resistance genes, not only among environmental bacteria but also to potential human pathogens (
57,
58). The co-occurrence of
P. aeruginosa and
E. coli in the same environment further increases the risk of gene exchange via plasmids and integrons, as both genera are known to participate in interspecies transfer of mobile genetic elements (
33,
50). This raises concerns about recreational and occupational exposure of local populations, particularly fishermen and coastal residents, who are in frequent contact with such waters (
59,
60).
Beyond antibiotic exposure, the presence of HMs in the Lagos marine environment may have contributed to the emergence and maintenance of AMR. Studies by Adeyemi et al. (
61), and Ita and Anwana (
62) have reported elevated levels of metals such as cadmium (Cd), lead (Pb), mercury (Hg), and zinc (Zn) in the Lagos coastal zone. The HMs exert co-selective pressure on bacterial populations by favoring strains that carry both metal-resistance genes (MRGs) and ARGs on the same genetic elements, such as plasmids and transposons (
23). Recent researches have shown that environmental contaminants like HMs and microplastics act not merely as passive pollutants but as active drivers of AMR evolution (
50,
63-
65). Historical genomic analyses have revealed that MRGs existed long before the clinical antibiotic era, and therefore suggest that ancient metal resistance mechanisms may have laid the genetic foundation for contemporary antibiotic resistance (
65-
67). Consequently, the interplay between antibiotic residues, HMs, and microbial communities in Lagos marine waters likely accelerates the co-selection and persistence of MDR phenotypes in environmental bacteria.
5.3. Public Health Significance
The global increase in antibiotic resistance is a serious threat since it reduces the ability of frequently administered antibiotics to treat common bacterial infections (
18-
21,
68). There are concerning patterns of resistance among important bacterial diseases, according to the 2022 global antimicrobial resistance and use surveillance system (GLASS) report. Due to its cross-border spread, AMR is a serious worldwide issue that affects nations of all economic levels. This crisis is fueled by a number of factors, including limited access to clean water, sanitation, and hygiene (WASH) for humans and animals; ineffective infection and disease prevention strategies in homes, hospitals, and agricultural settings; a lack of affordable vaccines, diagnostics, and treatments; a lack of knowledge and comprehension; and a lack of enforcement of pertinent laws (
68,
69). The origins and effects of AMR disproportionately affect populations in low-resource environments, making them more vulnerable (
68). Also, globally, public health systems and clinical facilities reflected the "COVID effect" on AMR (
70). Hospital-onset infections, which are often linked to AMR, were shown to be more common in patients with and without COVID-19 (
70). Increased equipment and invasive operations, a more critically ill patient case mix, intensive care unit (ICU) admission, immunological suppression and other predisposing conditions, and longer hospital stays that raise the risk of infection are some of the hypothesized reasons (
71,
72). Overcrowding, widespread antibiotic usage, and failures in infection control and antibiotic stewardship efforts due to time and resource constraints may have contributed to the onset and spread of AMR in hospital settings and communities during COVID-19 era (
70,
73). The AMR is a complicated issue that calls for targeted responses from a variety of industries, such as food production, animal health, human health, and environmental protection, in addition to a cooperative, cross-sectoral approach (
68). This study highlights that addressing AMR in human health necessitates prioritizing infection prevention to minimize unnecessary antimicrobial usage, guaranteeing fair access to high-quality diagnostics and treatments, and promoting innovation through focused initiatives such as AMR monitoring, tracking antimicrobial usage, and developing new vaccines, diagnostics, and treatment options.